Paul Darling

Principal
ZS Associates

Paul Darling is a Principal with ZS Associates in the firm’s San Francisco office. Paul assists life sciences companies in evaluating new markets, acquisitions, and licensing opportunities as well as developing the associated go-to-market strategies. He has presented at several industry conferences on the topics of forecasting, asset valuation, and alliance structuring.

Paul developed and leads ZS's Institute on U.S. Healthcare Evolution and Scenario Planning. He is currently exploring opportunities for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform, including new business models, therapies, acquisitions, and partnerships, as well as reimagining the commercial model to support such portfolio changes.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in Statistical Thermodynamics from Washington University.

Check out the incredible speaker line-up to see who will be joining Paul.

Download The Latest Agenda

Selecting the Channel Best Suited to Customer Engagement

Wednesday, January 4th, 2017

08:50 Keynote: Evolution of the U.S. Pharma Commercial Model in the New Healthcare Environment

• Industry evolution is driving change across the customer landscape, perceptions of value, and local ecosystem characteristics
• To thrive, pharma companies need to customize how they deliver value in this new healthcare era
• The commercial model and HQ organization must evolve to better engage customers, deliver value, and prepare for future portfolio additions

12:15 Interactive Roundtable Discussions

#1 Evolution of the U.S. Pharma Commercial Model in the New Healthcare Environment
Paul Darling, Principal, ZS Associates

#2 Mapping the Customer Journey to Create Positive Experiences that Engage Customers
Sandra Velez, Content Marketing Lead, Merck

#3 IMS Health Topic TBD
Justin Hawver, Sr Managed Services Consultant, IMS Health
Mark Klapper, Engagement Manager, IMS Health

#4 Getting the Most Out of Content and Inbound Marketing
Kevin Watson, Multichannel Marketing Engagement Lead, UCB

#5 Critical Decisions and Activities to Build a Commercial Infrastructure: Small Biopharma Perspective
Katie MacFarlane, Chief Commercial Officer, Agile Therapeutics

#6 Unlocking the Power of Clinical Diagnostics
Jason Bhan, Co-Founder, & Chief Medical Officer, Medivo

#7 Adobe Digital Index: state of digital healthcare
Tamara Gaffney, Adobe

#8 Specialty Care Data – Analytics
Ed Stelmack, AstraZeneca